Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E J, Kroot"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J W E, Hokken, A W L, van den Wall Bake, R N J, de Nijs, A A A, Westgeest, E J, Kroot, G, van Lijnschoten
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 152(12)
Eosinophilic fasciitis (EF) is a disease with unknown aetiology, although an immunologic pathogenesis is suspected. The characteristic features of this inflammatory disease include scleroderma-like skin indurations, predominantly on the extremities,
Publikováno v:
The Journal of rheumatology. 28(7)
To study the presence of chronic coexisting diseases in patients with rheumatoid arthritis (RA) and its effect on RA treatment, disease course, and outcome during the first years of the disease.From January 1985 to December 1990, 186 patients with re
Autor:
E J, Kroot, M G, Nieuwenhuizen, M C, de Waal Malefijt, P L, van Riel, P C, Pasker-de Jong, R F, Laan
Publikováno v:
Arthritis and rheumatism. 44(6)
Rheumatoid arthritis (RA) has been reported to be associated with bone loss during the first years of the disease. The magnitude of this problem after the initial years has not yet been evaluated. In the present study, the change in bone mineral dens
Autor:
E J, Kroot, B A, de Jong, M A, van Leeuwen, H, Swinkels, F H, van den Hoogen, M, van't Hof, L B, van de Putte, M H, van Rijswijk, W J, van Venrooij, P L, van Riel
Publikováno v:
Arthritis and rheumatism. 43(8)
To study the predictive value of anticyclic citrullinated peptide antibody (anti-CCP) in patients with recent-onset rheumatoid arthritis (RA).Outcome in terms of physical disability (Health Assessment Questionnaire) and radiologic damage (modified Sh
Publikováno v:
Rheumatology (Oxford, England). 38
Based on the results of a MEDLINE search (1992-1997), the term 'refractory rheumatoid arthritis' (refractory RA) is ill-defined, in terms of both patient characterization and description of previous treatments. Current strategies of management of ref